Thomas L. Holland, MD, professor of Medicine, Duke University School of Medicine discusses the ERADICATE Trial which studied the Ceftobiprole vs Daptomycin in Complicated Staphylococcus aureus Bacteremia cases.
Insights
Joshua Rosenberg, MD, leads a discussion around the REVISIT trial, which was a phase 3, randomized, multinational, open-label study that evaluated the efficacy and safety of aztreonam-avibactam compared to meropenem in hospitalized adults with serious Gram-negative bacterial infections, specifically complicated intra-abdominal infections (cIAI) and hospital-acquired/ventilator-associated pneumonia (HAP/VAP).
Recommendations for managing patients with HIV infections with newer antiretroviral treatment options, including once-daily single-tablet regimens.
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Approves Tebipenem Pivoxil as First Oral Carbapenem For Complicated Urinary Tract Infections
2
Reductions in Funding, Personnel Will Leave US Less Prepared for Future Infectious Disease Outbreaks
3
Screwworm: The Flesh-Eating Parasite Returning to the Spotlight
4
Bepirovirsen Phase 3 Results Offer Potential Cure for Chronic Hepatitis B
5